Development and in-vitro evaluation of Furosemide Solid Dispersion using different Water Soluble Carriers

L. Soni, M. Ansari, Nisha Thakre, Anjita Singh, M. Bhowmick, J. Rathi
{"title":"Development and in-vitro evaluation of Furosemide Solid Dispersion using different Water Soluble Carriers","authors":"L. Soni, M. Ansari, Nisha Thakre, Anjita Singh, M. Bhowmick, J. Rathi","doi":"10.21276/IJRDPL.2278-0238.2017.6(2).2571-2575","DOIUrl":null,"url":null,"abstract":"Objective: The objective of the present investigation was to improve solubility and dissolution characteristics of Furosemide, which might offer improved bioavailability. The bioavailability of the drug when taken orally is limited by the relatively low solubility. Furosemide is a loop diuretic (a ‘water pill’) used to treat congestive heart failure, oedema and sometimes hypertension. Method: The solid dispersion of Furosemide was prepared by Solvent evaporation method by using 1:1, 1:2 and 1:3 ratios of drug and polymers (PVP K-30, PEG6000). The solid dispersion was prepared by solvent evaporation method. The prepared solid dispersion was evaluated for various parameters like uniformity of drug content, in-vitro drug release and short term stability studies. Results: The prepared dispersion showed marked increase in the dissolution rate of Furosemide than that of pure drug and the in vitro release studies revealed that there was an improvement in the dissolution characteristics of drug when prepared as solid dispersions. Solid dispersion with PEG 6000 and PVPK30 gave better rate and extent of dissolution. Conclusion: It can be concluded that the solid dispersions prepared with PEG6000 and PVP K30 and among all the formulations, F6 has highest solubility and in vitro dissolution rate.","PeriodicalId":14206,"journal":{"name":"International Journal of Research and Development in Pharmacy and Life Sciences","volume":"45 1","pages":"2571-2575"},"PeriodicalIF":0.0000,"publicationDate":"2017-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Research and Development in Pharmacy and Life Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21276/IJRDPL.2278-0238.2017.6(2).2571-2575","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9

Abstract

Objective: The objective of the present investigation was to improve solubility and dissolution characteristics of Furosemide, which might offer improved bioavailability. The bioavailability of the drug when taken orally is limited by the relatively low solubility. Furosemide is a loop diuretic (a ‘water pill’) used to treat congestive heart failure, oedema and sometimes hypertension. Method: The solid dispersion of Furosemide was prepared by Solvent evaporation method by using 1:1, 1:2 and 1:3 ratios of drug and polymers (PVP K-30, PEG6000). The solid dispersion was prepared by solvent evaporation method. The prepared solid dispersion was evaluated for various parameters like uniformity of drug content, in-vitro drug release and short term stability studies. Results: The prepared dispersion showed marked increase in the dissolution rate of Furosemide than that of pure drug and the in vitro release studies revealed that there was an improvement in the dissolution characteristics of drug when prepared as solid dispersions. Solid dispersion with PEG 6000 and PVPK30 gave better rate and extent of dissolution. Conclusion: It can be concluded that the solid dispersions prepared with PEG6000 and PVP K30 and among all the formulations, F6 has highest solubility and in vitro dissolution rate.
不同水溶性载体呋塞米固体分散体的研制及体外评价
目的:改进速尿的溶解度和溶出度,提高其生物利用度。口服该药的生物利用度受溶解度较低的限制。速尿是一种循环利尿剂(一种“水丸”),用于治疗充血性心力衰竭、水肿,有时也用于高血压。方法:采用溶剂蒸发法,以1:1、1:2、1:3的药物与聚合物(PVP K-30、PEG6000)的比例制备呋塞米固体分散体。采用溶剂蒸发法制备固体分散体。对制备的固体分散体进行了药物含量均匀性、体外释放度和短期稳定性等参数的评价。结果:所制备的呋塞米分散体的溶出度明显高于纯药,体外释放研究表明,作为固体分散体制备时,药物的溶出特性有所改善。固相分散剂peg6000和PVPK30的溶出速率和溶出程度较好。结论:PEG6000和PVP K30制备的固体分散体中,F6的溶解度和体外溶出率最高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信